Bahrain has approved the emergency use of AstraZeneca’s anti-Covid drug Evusheld.
The kingdom has become the first country to authorise the drug, which will be available to adults 18 years and above, who are immunocompromised or who are taking immunosuppressive drugs or individuals with occupations that put them at risk of infection.
Click here to read more.
